治疗性递送系统需聚焦细胞精准性以靶向神经退行性变

by Lavanya Gupta, Sinem Agilkaya, Kim Susann Keller, Ebru Ercan-Herbst The central problem when delivering drugs to the brain is no longer crossing the blood–brain barrier, but delivering therapeutics to the right cells, in the right regions to target neurodegeneration, within a dynamically changing neurovascular unit. Crossing the blood–brain barrier is no longer a problem for delivering therapeutics to the brain. This Perspective argues that the main challenge is now how to deliver therapeutics to the right cells, in the right regions to target neurodegeneration, within a dynamically changing neurovascular unit.

中文翻译还没有生成，先显示原文。